389 related articles for article (PubMed ID: 27387699)
1. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m
Di J; Zhang H; Yu H; Zhang P; Wang Z; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1357-1363. PubMed ID: 27387699
[TBL] [Abstract][Full Text] [Related]
2. Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class.
Zhang H; Han X; Yu H; Di J; Zhang P; Jia W
Obes Surg; 2017 Jan; 27(1):134-142. PubMed ID: 27312346
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Fasting C-Peptide Predicts Type 2 Diabetes Mellitus Remission in Low-BMI Chinese Patients After Roux-en-Y Gastric Bypass.
Zhao L; Li W; Su Z; Liu Y; Zhu L; Zhu S
J Gastrointest Surg; 2018 Oct; 22(10):1672-1678. PubMed ID: 29845572
[TBL] [Abstract][Full Text] [Related]
4. "Dual-remission" after Roux-en-Y gastric bypass surgery: Glycemic variability cannot always be improved in Chinese obese patients with type 2 diabetes.
Yu H; Zhou J; Bao Y; Pin Zhang ; Lu W; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1312-1319. PubMed ID: 26823091
[TBL] [Abstract][Full Text] [Related]
5. Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2.
Yu H; Di J; Bao Y; Zhang P; Zhang L; Tu Y; Han X; Jia W
Surg Obes Relat Dis; 2015; 11(1):6-11. PubMed ID: 25547054
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the metabolic effects of LSG and LRYGB in Chinese diabetes patients with BMI<35 kg/m
Du X; Zhou HX; Zhang SQ; Tian HM; Zhou ZG; Cheng Z
Surg Obes Relat Dis; 2017 Feb; 13(2):189-197. PubMed ID: 27720418
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic gastric bypass for the treatment of type 2 diabetes: a comparison of Roux-en-Y versus single anastomosis gastric bypass.
Almalki OM; Lee WJ; Chong K; Ser KH; Lee YC; Chen SC
Surg Obes Relat Dis; 2018 Apr; 14(4):509-515. PubMed ID: 29555031
[TBL] [Abstract][Full Text] [Related]
8. Decreased serum betatrophin levels correlate with improved fasting plasma glucose and insulin secretion capacity after Roux-en-Y gastric bypass in obese Chinese patients with type 2 diabetes: a 1-year follow-up.
Guo K; Yu H; Lu J; Bao Y; Chen H; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1343-1348. PubMed ID: 27178609
[TBL] [Abstract][Full Text] [Related]
9. Decreased visceral fat area correlates with improved total testosterone levels after Roux-en-Y gastric bypass in obese Chinese males with type 2 diabetes: a 12-month follow-up.
Liu F; Tu Y; Zhang P; Bao Y; Han J; Jia W
Surg Obes Relat Dis; 2018 Apr; 14(4):462-468. PubMed ID: 29254689
[TBL] [Abstract][Full Text] [Related]
10. A Prospective Single-Arm Trial of Modified Long Biliopancreatic and Short Alimentary Limbs Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity.
Murad AJ; Cohen RV; de Godoy EP; Scheibe CL; Campelo GP; Ramos AC; de Lima RC; Pinto LEV; Coelho D; Costa HBF; Pinto ÍMP; Pereira T; Teófilo FRS; Valadão JA
Obes Surg; 2018 Mar; 28(3):599-605. PubMed ID: 28933045
[TBL] [Abstract][Full Text] [Related]
11. Effects of gastric bypass on type 2 diabetes in patients with BMI 30 to 35.
Scopinaro N; Adami GF; Papadia FS; Camerini G; Carlini F; Briatore L; Andraghetti G; Catalano M; Cordera R
Obes Surg; 2014 Jul; 24(7):1036-43. PubMed ID: 24647849
[TBL] [Abstract][Full Text] [Related]
12. Defining and predicting complete remission of type 2 diabetes: a short-term efficacy study of open gastric bypass.
Yan H; Tang L; Chen T; Kral JG; Jiang L; Li Y; Hu R; Cui J; Li S; Tian F
Obes Facts; 2013; 6(2):176-84. PubMed ID: 23594442
[TBL] [Abstract][Full Text] [Related]
13. Roux-en-Y Gastric Bypass for T2D Treatment in Chinese Patients with Low BMI: 5-Year Outcomes.
Wang C; Zhang H; Yu H; Bao Y; Zhang P; Di J
Obes Surg; 2020 Jul; 30(7):2588-2597. PubMed ID: 32157522
[TBL] [Abstract][Full Text] [Related]
14. Roux-en-Y gastric bypass for nonobese patients with uncontrolled type 2 diabetes: a long-term evaluation.
Ferraz ÁAB; de Sá VCT; Santa-Cruz F; Siqueira LT; Silva LB; Campos JM
Surg Obes Relat Dis; 2019 May; 15(5):682-687. PubMed ID: 31005458
[TBL] [Abstract][Full Text] [Related]
15. Cost-Utility of Laparoscopic Roux-en-Y Gastric Bypass in Chinese Patients with Type 2 Diabetes and Obesity with a BMI ≥ 27.5 kg/m2: a Multi-Center Study with a 4-Year Follow-Up of Surgical Cohort.
Tu Y; Wang L; Wei L; Xu Y; Han X; Han J; Yu H; Zheng C; Bao Y; Jia W
Obes Surg; 2019 Dec; 29(12):3978-3986. PubMed ID: 31338737
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Surgery Comparing Sleeve Gastrectomy with Jejunal Bypass and Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients After 3 Years.
Sepúlveda M; Alamo M; Preiss Y; Valderas JP
Obes Surg; 2018 Nov; 28(11):3466-3473. PubMed ID: 30069859
[TBL] [Abstract][Full Text] [Related]
17. Ethnicity Does Not Influence Glycemic Outcomes or Diabetes Remission After Sleeve Gastrectomy or Gastric Bypass in a Multiethnic Asian Cohort.
Lee PC; Tham KW; Ganguly S; Tan HC; Eng AKH; Dixon JB
Obes Surg; 2018 Jun; 28(6):1511-1518. PubMed ID: 29280058
[TBL] [Abstract][Full Text] [Related]
18. Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.
Aarts EO; Janssen J; Janssen IM; Berends FJ; Telting D; de Boer H
Obes Surg; 2013 Jul; 23(7):867-73. PubMed ID: 23475775
[TBL] [Abstract][Full Text] [Related]
19. Two-year outcomes of Roux-en-Y gastric bypass vs medical treatment in type 2 diabetes with a body mass index lower than 32.5 kg/m
Ling J; Tang H; Meng H; Wu L; Zhu L; Zhu S
J Endocrinol Invest; 2022 Sep; 45(9):1729-1740. PubMed ID: 35596918
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques.
Robert M; Ferrand-Gaillard C; Disse E; Espalieu P; Simon C; Laville M; Gouillat C; Thivolet C
Obes Surg; 2013 Jun; 23(6):770-5. PubMed ID: 23355293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
